Research Article
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
Table 2
Concentrations (; pg/ml) of TGF-β1, TGF-β2, and TGF-β3 in serum and AH of healthy individuals (controls) and diabetic patients with different stages of DR. The fold change for each group was calculated relative to the control group.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Factor of change compared to healthy controls. |